Medicine Compliance Among Hypertensive Patients with Known Diabetes Mellitus in Sindh, Pakistan
Compliance Among Hypertensive and Diabetic Patients in Sindh
DOI:
https://doi.org/10.61919/jhrr.v4i3.1528Keywords:
Hypertension, diabetes mellitus, medication compliance, non-compliance, chronic disease management, healthcare barriers, Sindh.Abstract
Background: Hypertension and diabetes mellitus are prevalent chronic conditions, requiring long-term medication adherence for effective management. Non-compliance can lead to severe health complications and increased healthcare costs.
Objective: To evaluate medication compliance among hypertensive patients with known diabetes mellitus in Sindh, Pakistan, and identify key factors contributing to non-compliance.
Methods: This cross-sectional study included 381 participants from various cities in Sindh, selected through convenience sampling. Data were collected using a structured questionnaire covering demographic characteristics, socioeconomic status, and factors influencing medication compliance. Blood pressure was recorded using a sphygmomanometer. Ethical approval was obtained, and data were analyzed using SPSS version 25, with a p-value < 0.05 considered statistically significant.
Results: Of the 381 participants, 67.98% were fully compliant with their medication regimen, while 32.02% were non-compliant. The most common reasons for non-compliance were complex medication regimens (17.21%), side effects (16.39%), and financial constraints (13.93%). Socioeconomic status significantly influenced compliance, with lower compliance observed in the lower socioeconomic group (p < 0.05).
Conclusion: Despite a high compliance rate, a substantial portion of patients remain non-compliant due to regimen complexity and financial barriers. Targeted interventions, including simplified treatment plans and improved patient education, are necessary.
Downloads
References
Yao Q, Liu C, Zhang Y, Xu L. Health-Related Quality Of Life Of People With Self-Reported Hypertension: A National Cross-Sectional Survey In China. Int J Environ Res Public Health. 2019;16(10):1721. doi: 10.3390/ijerph16101721.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global Burden Of Hypertension: Analysis Of Worldwide Data. Lancet. 2005;365(9455):217–23. doi: 10.1016/S0140-6736(05)17741-1.
Mohsen IM. Hypertension In Developing Countries: A Major Challenge For The Future. Curr Hypertens Rep. 2018;20(5):38. doi: 10.1007/s11906-018-0839-1.
Prabhakaran D, Jeemon P, Ghosh S, Shivashankar R, Ajay VS, Kondal D, et al. Prevalence And Incidence Of Hypertension: Results From A Representative Cohort Of Over 16,000 Adults In Three Cities Of South Asia. Indian Heart J. 2017;69(4):434–41. doi: 10.1016/j.ihj.2017.05.021.
Basit A, Tanveer S, Fawwad A, Naeem N, NDSP Members. Prevalence And Contributing Risk Factors For Hypertension In Urban And Rural Areas Of Pakistan; A Study From Second National Diabetes Survey Of Pakistan (NDSP) 2016–2017. Clin Exp Hypertens. 2020;42(3):218–24. doi: 10.1080/10641963.2019.1619753.
Shafi ST, Shafi T. A Survey Of Hypertension Prevalence, Awareness, Treatment, And Control In Health Screening Camps Of Rural Central Punjab, Pakistan. J Epidemiol Glob Health. 2017;7(2):135–40. doi: 10.1016/j.jegh.2017.01.001.
World Health Organization. Cardiovascular Diseases. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.
Wikipedia. Pakistan. Available from: https://en.wikipedia.org/wiki/Pakistan.
Hassan A, Mahmood K, Allah Buksh H. Healthcare System Of Pakistan. Int J Adv Res Publ. 2017;1(4):170-3.
WHO EMRO. Health Service Delivery. Available from: https://www.emro.who.int/pak/programmes/service-delivery.html.
Barolia R, Sayani AH. Risk Factors Of Cardiovascular Disease And Its Recommendations In Pakistani Context. J Pak Med Assoc. 2017;67(11):1723–9.
Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, et al. The Need For Obtaining Accurate Nationwide Estimates Of Diabetes Prevalence In India—Rationale For A National Study On Diabetes. Indian J Med Res. 2011;133:369–80.
Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The Significance Of Compliance And Persistence In The Treatment Of Diabetes, Hypertension And Dyslipidaemia: A Review. Int J Clin Pract. 2008;62:76–87.
Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, et al. Recommendations For Evaluating Compliance And Persistence With Hypertension Therapy Using Retrospective Data. Hypertension. 2006;47:1039–48.
Sweileh WM, Aker O, Hamooz S. Rate Of Compliance Among Patients With Diabetes Mellitus And Hypertension. An-Najah Univ J Res A Nat Sci. 2005;19:1–12.
Thrall G, Lip GY, Lane D. Compliance With Pharmacological Therapy In Hypertension: Can We Do Better, And How? J Hum Hypertens. 2004;18:595–7.
Srinivas G, Suresh E, Jagadeesan M, Amalraj E, Datta M. Treatment-Seeking Behavior And Compliance Of Diabetic Patients In A Rural Area Of South India. Ann N Y Acad Sci. 2002;958:420–4.
Rao CR, Kamath VG, Shetty A, Kamath A. Treatment Compliance Among Patients With Hypertension And Type 2 Diabetes Mellitus In A Coastal Population Of Southern India. Int J Prev Med. 2014;5(8):992-8.
Elahi A, Ali AA, Khan AH, Samad Z, Shahab H, Aziz N, et al. Challenges Of Managing Hypertension In Pakistan – A Review. Clin Hypertens. 2023;29(1):17. doi: 10.1186/s40885-023-00245-6.
Reddy Peddi D, Pallekonda H, Reddy V. Evaluation Of The Prevalence And Risk Factors Of Drug-Related Problems In Hypertension And Type 2 Diabetes Mellitus Patients At A Tertiary Care Hospital: A Cross-Sectional Study. Cureus. 2023;15(7)
. doi: 10.7759/cureus.42775.
Nutakor JA, Zhou L, Larnyo E, Addai-Danso S, Tripura D. Socioeconomic Status And Quality Of Life: An Assessment Of The Mediating Effect Of Social Capital. Healthcare (Basel). 2023;11(5):749. doi: 10.3390/healthcare11050749.
Rohatgi KW, Humble S, McQueen A, Hunleth JM, Chang SH, Herrick CJ, et al. Medication Adherence And Characteristics Of Patients Who Spend Less On Basic Needs To Afford Medications. J Am Board Fam Med. 2021;34(3):561–70. doi: 10.3122/jabfm.2021.03.200361.
Jimmy B, Jose J. Patient Medication Adherence: Measures In Daily Practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38.
Hamrahian SM, Maarouf OH, Fülöp T. A Critical Review Of Medication Adherence In Hypertension: Barriers And Facilitators Clinicians Should Consider. Patient Prefer Adherence. 2022;16:2749–57. doi: 10.2147/PPA.S368784.
Tiwary A, Rimal A, Paudyal B, Sigdel KR, Basnyat B. Poor Communication By Healthcare Professionals May Lead To Life-Threatening Complications: Examples From Two Case Reports. Wellcome Open Res. 2019;4:7. doi: 10.12688/wellcomeopenres.15042.1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Parus Saleem, Muhammad Sikandar Arain, Sidra-tul-Muntaha, Aqsa Kalhoro, Hira, Zoha Sattar Khuharo, Faryal Burfat, Harima Shahnawaz, Abdul Razzaque Nohri
This work is licensed under a Creative Commons Attribution 4.0 International License.
